ATOPIC DERMATITIS (AD)

This study is testing whether an experimental oral medication called HSK44459 can improve skin symptoms and reduce itching in adults with moderate-to-severe atopic dermatitis (eczema). Researchers will compare two different doses of the medication against a placebo pill over 12 w…

This is an early safety study testing a new oral medication called ENV-294 for adults with moderate-to-severe atopic dermatitis (eczema). The main goal is to see if the drug is safe and well-tolerated when taken daily for 28 days. Researchers will also check if it helps reduce ec…

This study is testing whether an oral tablet called QY201 can help adults with moderate to severe atopic dermatitis, also known as eczema. Researchers will compare the pill to a placebo (a dummy pill) to see if it reduces skin inflammation and itching over 16 weeks. The trial is …

This is the first human study of an experimental drug called ATTO1310. Researchers want to see if it's safe and how it moves through the body in healthy volunteers and people with atopic dermatitis (eczema) or chronic itching. The study will compare the drug to a placebo (inactiv…

This is the very first study in humans for a new potential eczema (atopic dermatitis) treatment called GB-7624. It will test the safety and side effects of single and multiple doses in 40 healthy adult volunteers. The main goal is to see how the body handles the drug and what dos…